Abstract
Introduction: Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction associated with post-synaptic skeletal muscle membrane protein autoantibodies against the nicotinic acetylcholine receptors (ACh-R), muscle-specific kinase (MuSK) or agrin and lipoprotein receptor-related protein 4 (LRP4). The disease pathomechanism is complex, with predisposing human leukocyte antigen genes, pro-inflammatory cytokine profile, sex hormones, pharmacological agents, and environmental triggers. Several case reports suggest SARS-CoV-2 infection and Covid-19 vaccines as a possible trigger of MG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.